DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Medplus Health Services Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·17 Oct 2026, 9:18 am

Medplus Health Services

Medplus Health Services Limited has informed stock exchanges about its upcoming meeting with analysts and institutional investors. This communication is part of the company's standard regulatory compliance to keep the market updated on its investor relations activities.

For investors, such meetings are significant because they provide a platform for management to discuss future strategy, operational performance, and market outlook directly with the financial community. While the company has not disclosed specific details in this filing, the event offers a window into the company's current thinking and could signal upcoming business developments.

What to watch next is the official agenda and any specific guidance the management provides during the meet. Investors should look for updates on expansion plans, margin trends, or any commentary on the broader healthcare sector to gauge the company's medium-term trajectory.